Although there is consensus on the pro-differentiative effects of PPARδ ligands and PPARδ activation in KCs, the effects on KC proliferation are more controversial, with studies showing reduced [60] or enhanced [31] KC proliferation after treatment with the PPARδ ligand L-165041 or GW-501516. This evidence concerns the gene PPARD and keratoconus.